GlassScriptPhysician profile
Andrew Bearb
NPI 1720738800
$329.62
in general payments reported to CMS, 2019-2025
11 companies · $99.12 in 2025
The $99.12 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $73.34 · 2023: $57.98 · 2024: $99.18 · 2025: $99.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $73.34 | 2022 | |
| Astellas Pharma US INC | $64.28 | 2023-2024 | Veozah |
| Abbvie INC. | $35.77 | 2025 | |
| Intuitive Surgical, INC. | $31.12 | 2025 | |
| Novo Nordisk INC | $23.36 | 2024 | Wegovy |
| Abbott Laboratories | $22.40 | 2023 | Freestyle Libre 3 |
| Esperion Therapeutics, INC. | $18.32 | 2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $16.07 | 2023 | Camzyos |
| Lilly USA, LLC | $15.54 | 2024 | Zepbound, Mounjaro |
| Exact Sciences Corporation | $15.51 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $13.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bearb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.